RBM33 and triple-A syndrome: Functionally, we confirmed that the overexpression of circRBM33 in VSMCs significantly increased the mRNA and protein expression of EPHB2, and inhibited TIMP-1 expression, suggesting circ-RBM33 contributes to AAA progression by regulating ECM degradation.